These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6327037

  • 1. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N, Schütte J, Schmidt CG, Seeber S.
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [Abstract] [Full Text] [Related]

  • 2. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H.
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
    Daugaard G, Hansen HH, Rørth M.
    Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
    [Abstract] [Full Text] [Related]

  • 4. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
    Niederle N, Schütte J, Krischke W, Seeber S, Schmidt CG.
    Klin Wochenschr; 1984 Aug 16; 62(16):783-6. PubMed ID: 6090762
    [Abstract] [Full Text] [Related]

  • 5. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct 16; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 6. [Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
    Höfeler H, Höffken K, Niederle N, Schoetensack B, Wandl U, Kath R, Müller M, Schmidt CG.
    Dtsch Med Wochenschr; 1986 Dec 19; 111(51-52):1961-6. PubMed ID: 3024948
    [Abstract] [Full Text] [Related]

  • 7. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
    Akiyama J, Sato A, Honda K, Chida K, Watanabe T, Okano H, Okano A, Taniguchi M, Genma H, Aoki H.
    Gan To Kagaku Ryoho; 1991 Mar 19; 18(3):419-24. PubMed ID: 1848420
    [Abstract] [Full Text] [Related]

  • 8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Mar 19; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ, Arnold E, Walter M, Sander U.
    Fortschr Med; 1984 Sep 06; 102(33):811-4. PubMed ID: 6090286
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Sep 06; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 06; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D, Gralla R, Stoopler M, Casper E, Cheng E, Kosloff C, Golbey R.
    Cancer Treat Rep; 1982 Feb 06; 66(2):247-51. PubMed ID: 7034932
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
    Klastersky J, Sculier JP, Nicaise C, Weerts D, Mairesse M, Libert P, Rocmans P, Michel J, Ferremans W.
    Cancer Treat Rep; 1983 Feb 06; 67(7-8):727-30. PubMed ID: 6347374
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Drings P, Manke HG.
    Strahlentherapie; 1985 Mar 06; 161(3):131-3. PubMed ID: 2983459
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP, Bains M, Chapman R, Golbey R.
    Cancer Treat Rep; 1981 Mar 06; 65(9-10):781-5. PubMed ID: 6168370
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 06; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.